AMERIPRISE FINANCIAL INC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of PULMONX CORP
ValueSharesWeighting
Q2 2022$701,000
-55.5%
47,625
-24.9%
0.00%
Q1 2022$1,574,000
-22.5%
63,430
+0.2%
0.00%
-100.0%
Q4 2021$2,031,000
+20.5%
63,325
+35.2%
0.00%0.0%
Q3 2021$1,685,000
-22.7%
46,825
-5.3%
0.00%0.0%
Q2 2021$2,181,000
-3.5%
49,4250.0%0.00%0.0%
Q1 2021$2,261,000
-31.0%
49,425
+4.0%
0.00%0.0%
Q4 2020$3,279,00047,5150.00%
Other shareholders
PULMONX CORP shareholders Q3 2021
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders